Furthermore, miR-181c in HCC cells presents characteristic direct interaction with SPP1 as an up-streaming inhibitor, which strongly suggests new strategies in HCC research and treatment for establishing interventional practice at the molecular level. This evidence concerns the gene SPP1 and hepatocellular carcinoma.